Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01620008 · ClinicalTrials.gov registry record · NA
Delayed Cord Clamping and Infant Brain Study
A NA study of Iron-deficiency, sponsored by University of Rhode Island.
- Completed
- Registry status
- NA
- Development phase
- 106
- Enrollment target
- 1
- Study location
NCT01620008: Completed NA study of Iron-deficiency, sponsored by University of Rhode Island.
NCT01620008 is a NA study of Iron-deficiency that has completed, run by University of Rhode Island. The registered enrollment target is 106 participants, below the 192-participant average among 16 other Iron-deficiency trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01620008, a NA study of Iron-deficiency, has completed, sponsored by University of Rhode Island.
- COMPLETED
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if delaying cord clamping at the birth of term infants effects the early brain development (myelin deposition)as determined by quantitative MRI at 4 and 10 months and developmental testing at 4, 10 and 24 months. This study will help to establish a scientific basis for the timing of cord clamping with reference to brain development.
Primary Outcome
At 4 months of age, term infants exposed to delayed cord clamping will have greater myelin content when compared to infants exposed to immediate cord clamping
Conditions Studied
Interventions
- PROCEDURE Delayed Cord Clamping
Study Locations (1)
Rhode Island
- Women & Infants Hospital of Rhode Island - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2012-10-01 |
| Est. Completion | 2018-12-31 |
| Phase | NA |
What the finished NCT01620008 record still lists
NCT01620008 is an interventional study that assigns participants to a tested intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, below the 192-participant average among 16 other Iron-deficiency trials with a reported enrollment target (45% lower).
The record links to 1 condition, with Iron-deficiency appearing as the primary indexed condition, and to 1 intervention - of which Delayed Cord Clamping is the first listed.
NCT01620008 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT01620008 about?
NCT01620008 is a clinical study titled "Delayed Cord Clamping and Infant Brain Study". The purpose of this study is to determine if delaying cord clamping at the birth of term infants effects the early brain development (myelin deposition)as determined by quantitative MRI at 4 and 10 months and developmental testing at 4, 10 and 24 months. This study will help to establish a scientifi...
What is the current status of trial NCT01620008?
This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2012-10-01. Estimated completion is 2018-12-31.
What conditions does trial NCT01620008 study?
This clinical trial studies the following conditions: Iron-deficiency.
What interventions are being tested in trial NCT01620008?
The interventions under investigation include: Delayed Cord Clamping (PROCEDURE).
Who is sponsoring clinical trial NCT01620008?
This trial is sponsored by University of Rhode Island, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01620008 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Iron-deficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01620008's enrollment target sits among peer trials
106 7th of 16 higher than 10 of 16 other Iron-deficiency trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Iron-deficiency trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Randomized Placebo Controlled Pilot Study of Probiotic Supplementation in At-risk Pregnant Women
COMPLETED · NA
-
Effect of Iron Supplements on the Growth of Enteric Pathogens
COMPLETED · NA
-
Improving the Iron Status of Athletes With Pre-, Pro- and Synbiotics
COMPLETED · NA
-
Feasibility or Oral Lactoferrin to Prevent Iron Deficiency Anemia in Obese Pregnancy
COMPLETED · NA
-
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
COMPLETED · NA
-
Effect of Vitamin C on Iron Absorption
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03181048 · 106 participants · NA
Clinical Trial of Concomitant Hip Arthroscopy During PAO
- NCT04682158 · 106 participants · Phase 2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- NCT04724018 · 106 participants · Phase 1
Sacituzumab Govitecan Plus EV in Metastatic UC
- NCT04798274 · 106 participants · NA
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI